Weizmann News
Valeria Rosenbloom and the late Mike Rosenbloom (z”l)
Press Release | News From The Institute | Donor Spotlights
Focused on how the brain enriches our lives, the investment will establish the Mike and Valeria Rosenbloom Center for Research on Positive Neuroscience
Press Release | News From The Institute | Donor Spotlights
This donation — among the largest of its kind for the Foundation — will establish The Azrieli Institute for Brain and Neural Sciences at The Weizmann Institute of Science.
Press Release
Montreal (August 12, 2020) - Weizmann Canada has announced that Stephen Bear and Zachary Schwartz have been elected to its Board of Directors.
Press Release | Science Stories
Researchers at the Weizmann Institute of Science have shown in mice that intestinal microbes, collectively termed the gut microbiome, may affect the course of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. As reported today in Nature, progression of an ALS-like disease was slowed after the mice received certain strains of gut microbes or substances known to be secreted by these microbes. Preliminary results suggest that the findings on the regulatory function of the microbiome may be applicable to human patients with ALS.
Press Release | News From The Institute
“Size is not everything,” proclaims a Nature press release today. “Some smaller institutes are punching above their weight.”
Press Release | News From The Institute
At the tender age of 20, Daniel Zajfman decided to make aliyah on his own. Just 15 years later, he’d been offered professorships at the Technion-Israel Institute of Technology and the Weizmann Institute of Science, Israel’s two premiere institutions for scientific research.